These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29592874)

  • 21. Using deep sequencing data for identification of editing sites in mature miRNAs.
    Alon S; Eisenberg E
    Methods Mol Biol; 2015; 1269():231-42. PubMed ID: 25577382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EndoVIPER-seq for Improved Detection of A-to-I Editing Sites in Cellular RNA.
    Knutson SD; Heemstra JM
    Curr Protoc Chem Biol; 2020 Jun; 12(2):e82. PubMed ID: 32469473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA Editing in Human and Mouse Tissues.
    Srinivasan H; Kok EPL; Tan MH
    Methods Mol Biol; 2021; 2181():163-176. PubMed ID: 32729080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein recoding by ADAR1-mediated RNA editing is not essential for normal development and homeostasis.
    Heraud-Farlow JE; Chalk AM; Linder SE; Li Q; Taylor S; White JM; Pang L; Liddicoat BJ; Gupte A; Li JB; Walkley CR
    Genome Biol; 2017 Sep; 18(1):166. PubMed ID: 28874170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for the Detection of Adenosine-to-Inosine Editing Events in Cellular RNA.
    Oakes E; Vadlamani P; Hundley HA
    Methods Mol Biol; 2017; 1648():103-127. PubMed ID: 28766293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In search of critical dsRNA targets of ADAR1.
    Levanon EY; Cohen-Fultheim R; Eisenberg E
    Trends Genet; 2024 Mar; 40(3):250-259. PubMed ID: 38160061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation.
    Yang JH; Luo X; Nie Y; Su Y; Zhao Q; Kabir K; Zhang D; Rabinovici R
    Immunology; 2003 May; 109(1):15-23. PubMed ID: 12709013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative Analysis of Adenosine-to-Inosine RNA Editing.
    Malik TN; Cartailler JP; Emeson RB
    Methods Mol Biol; 2021; 2181():97-111. PubMed ID: 32729077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine-to-inosine RNA editing: perspectives and predictions.
    Hoopengardner B
    Mini Rev Med Chem; 2006 Nov; 6(11):1213-6. PubMed ID: 17100632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-stranded RNA induces an antiviral defense status in epidermal keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-mediated differential signaling.
    Kalali BN; Köllisch G; Mages J; Müller T; Bauer S; Wagner H; Ring J; Lang R; Mempel M; Ollert M
    J Immunol; 2008 Aug; 181(4):2694-704. PubMed ID: 18684960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
    Gu T; Fu AQ; Bolt MJ; White KP
    JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovering A-to-I RNA Editing Through Chemical Methodology "ICE-seq".
    Sakurai M; Okada S; Ueda H; Yang Y
    Methods Mol Biol; 2021; 2181():113-148. PubMed ID: 32729078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A protein-protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme.
    Rajendren S; Manning AC; Al-Awadi H; Yamada K; Takagi Y; Hundley HA
    Nucleic Acids Res; 2018 Oct; 46(18):9647-9659. PubMed ID: 30202880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of A-to-I RNA editing: dotting the i's in the human transcriptome.
    Kiran A; Loughran G; O'Mahony JJ; Baranov PV
    Biochemistry (Mosc); 2011 Aug; 76(8):915-23. PubMed ID: 22022965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. irCLASH reveals RNA substrates recognized by human ADARs.
    Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R
    Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics.
    Nakano M; Nakajima M
    Pharmacol Ther; 2018 Jan; 181():13-21. PubMed ID: 28716651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA editome imbalance in hepatocellular carcinoma.
    Qi L; Chan TH; Tenen DG; Chen L
    Cancer Res; 2014 Mar; 74(5):1301-6. PubMed ID: 24556721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
    Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L
    Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the principles of the RNA editing code via large-scale systematic probing.
    Uzonyi A; Nir R; Shliefer O; Stern-Ginossar N; Antebi Y; Stelzer Y; Levanon EY; Schwartz S
    Mol Cell; 2021 Jun; 81(11):2374-2387.e3. PubMed ID: 33905683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.